To test if circulating platelets of patients with COVID-19 had a different responsiveness to agonists, we stimulated the platelets directly in whole blood and measured their ability to increase P-selectin exposure and integrin αIIbβ3 activation relative to the nonstimulated conditions (Figure 3A, B). This evidence concerns the gene SELP and COVID-19.